Myeloid Therapeutics
Clinical trials sponsored by Myeloid Therapeutics, explained in plain language.
-
New cancer drug enters first human trials for Tough-to-Treat tumors
Disease control Recruiting nowThis is the first study in people to test an experimental drug called MT-304 for advanced cancers that have a protein called HER2. The main goals are to check if the drug is safe, find the best dose, and see if it helps control the cancer. About 60 adults will receive MT-304 by i…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
First patients to receive experimental liver cancer drug
Disease control Recruiting nowThis is the first study in humans testing a new drug called MT-303 for advanced liver cancer that has spread or cannot be removed by surgery. Researchers will give the drug alone or combined with standard cancer medications to 70 participants to find the safest dose and see if it…
Phase: PHASE1 • Sponsor: Myeloid Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC